# Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)

> **NCT00393211** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 319 (actual)

## Conditions studied

- Recurrent Low Back Pain

## Interventions

- **DRUG:** MK0663, Etoricoxib / Duration of Treatment : 12 Weeks
- **DRUG:** Comparator : placebo (unspecified) /Duration of Treatment : 12 Weeks

## Key facts

- **NCT ID:** NCT00393211
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-04
- **Primary completion:** 2000-11
- **Final completion:** 2000-11
- **Target enrollment:** 319 (ACTUAL)
- **Last updated:** 2022-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00393211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00393211, "Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00393211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*